1.4 — References
Letters of authorization, right of reference statements, and cross-references to other applications
Requirements by Phase
Letters of authorization, right of reference statements, and cross-references to other applications
Requirements by Phase
IND Phase 1: optional IND Phase 2: optional IND Phase 3: optional NDA: required
Content Requirements
- Letters of authorization from referenced application holders
- Right of reference statements
- List of authorized studies with study identifiers
- Cross-references to other INDs, NDAs, DMFs, or master files
Expected Deliverables
- Letters of authorization
- Right of reference statements
- Cross-reference list
ICH Guidelines: 21 CFR 312.23
Source: 21 CFR 312.23
References
Sections
Related Sections
Up toModule 1: Administrative Information and Prescribing InformationComplete table of contents for the submission
Cover letter identifying the IND submission type, serial number, and key information
Administrative information including contact details, certifications, and financial disclosures
Application status requests including withdrawal, inactivation, and reactivation
Meeting requests and minutes for pre-IND, pre-NDA/BLA, and Type A/B/C meetings
+6 more sections
Check your compliance against this section
Upload your study data and get instant gap analysis with specific regulatory citations.
Try Compliance Check